HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.
No treatment is 100% effective.
Protocols combine treatments.
Early trials in China show CQ results in shorter hospital stays and improved patient outcomes.
Jiang et al., 20 Feb 2020, peer-reviewed, 1 author.
